Senior insider sale
Chief Operating Officer at CRINETICS PHARMACEUTICALS, INC. — senior position signals high conviction
$3.96M
99.51K shares
What this filing means
KNIGHT JEFF E. plans to sell 99.51K shares of CRINETICS PHARMACEUTICALS, INC. valued at approximately $3.96M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/13/2026ACC: 0001950047-26-003400
Officer· Chief Operating Officer
Since Aug 2021
99.51K
Shares to sell
$3.96M
Approx. market value
4.43K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
4/13/2026
4.43KTotal acquired4.43K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/13/2026 | Exercise of Stock Options Cash | 4.43K | — |
| Total | 4.43K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
85.16K
Market value
$3.41M
4/8/2026
—Completed
Units to sell
9.91K
Market value
$370.4K
3/16/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.43K
Market value
$174.9K
4/13/2026
Total
Units
99.51K
Value
$3.96M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/8/2026 | 85.16K | $3.41M | — | Completed |
3/16/2026 | 9.91K | $370.4K | — | Completed |
| Planned — Approximate Date | ||||
4/13/2026 | 4.43K | $174.9K | NASDAQ | Planned |
| Total | 99.51K | $3.96M | ||